2026 Q2 Portfolio Activity
In 2026 Q2, Eversept Partners, LP maintained a portfolio of 152 distinct positions. The most significant new addition was CARETRUST REIT INC, now representing 2.24% of the total fund value. They heavily accumulated shares in ENSIGN GROUP INC, increasing the position by 3978.8%. The fund also reduced its exposure to GSK PLC by 73.0%.
Position History
hover any row below to update
Loading…
Total Positions
152
Quarter
2026 Q2
Top Holding
UTHR (8.1%)
Top 10 Concentration
45.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 152
Eversept Partners, LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
UTHR
UNITED THERAPEU...
|
Healthcare | 8.09% | 8.26% |
#1
Prev: #1
|
7.2 |
—
|
23,397 | 8.9% |
P
S
|
287,668 | $155,867,152 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 6.32% | 5.49% |
#2
1
Prev: #3
|
4.5 |
—
|
-20,543 | -2.2% |
P
S
|
913,880 | $121,783,649 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EHC
ENCOMPASS HEALT...
|
Healthcare | 5.38% | 0.99% |
#3
24
Prev: #27
|
6.2 |
—
|
832,815 | 429.1% |
P
S
|
1,026,919 | $103,800,973 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENSG
ENSIGN GROUP IN...
|
Healthcare | 5.01% | 0.16% |
#4
72
Prev: #76
|
5.5 |
—
|
587,318 | 3978.8% |
P
S
|
602,079 | $96,513,264 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 4.93% | 4.61% |
#5
Prev: #5
|
3.0 |
—
|
39,484 | 1.8% |
P
S
|
2,212,770 | $94,949,961 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QQQ
PUT
INVESCO QQQ TR
|
PUT Option | 3.77% | 7.26% |
#6
4
Prev: #2
|
1.5 |
—
|
-140,100 | -58.7% |
P
S
|
98,600 | $72,609,040 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 3.45% | 2.99% |
#7
2
Prev: #9
|
1.9 |
—
|
-2,075 | -0.1% |
P
S
|
1,785,941 | $66,454,865 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 3.17% | 3.55% |
#8
Prev: #8
|
1.8 |
—
|
-87,412 | -3.0% |
P
S
|
2,798,210 | $61,168,871 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BKD
BROOKDALE SR LI...
|
Healthcare | 2.84% | 2.57% |
#9
2
Prev: #11
|
1.6 |
—
|
-172,085 | -4.8% |
P
S
|
3,396,470 | $54,649,202 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 2.73% | 2.50% |
#10
2
Prev: #12
|
3.1 |
—
|
32,584 | 5.2% |
P
S
|
664,684 | $52,702,794 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NTRA
NATERA INC
|
Healthcare | 2.48% | 4.06% |
#11
5
Prev: #6
|
1.0 |
—
|
-208,906 | -54.3% |
P
S
|
175,807 | $47,722,810 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.35% | 0.85% |
#12
17
Prev: #29
|
3.4 |
—
|
256,363 | 47.2% |
P
S
|
798,973 | $45,389,656 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTRE
CARETRUST REIT ...
|
Real Estate | 2.24% | — |
#13
Prev: #—
|
4.4 |
—
|
1,072,015 | — |
NEW
|
1,072,015 | $43,255,805 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HCA
HCA HEALTHCARE ...
|
Healthcare | 1.99% | 1.98% |
#14
Prev: #14
|
3.3 |
—
|
19,023 | 24.0% |
P
S
|
98,252 | $38,307,472 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 1.90% | 2.83% |
#15
5
Prev: #10
|
0.8 |
—
|
-294,241 | -31.8% |
P
S
|
629,952 | $36,619,110 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 1.77% | 1.35% |
#16
6
Prev: #22
|
0.7 |
—
|
-248,740 | -36.7% |
P
S
|
428,652 | $34,176,424 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYH
COMMUNITY HEALT...
|
Healthcare | 1.36% | 1.35% |
#17
6
Prev: #23
|
1.0 |
—
|
-812,706 | -9.4% |
P
S
|
7,864,575 | $26,267,680 | 2019 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GSK
GSK PLC
|
Healthcare | 1.31% | 5.20% |
#18
14
Prev: #4
|
0.5 |
—
|
-1,303,342 | -73.0% |
P
S
|
481,833 | $25,257,686 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CHE
CHEMED CORP NEW
|
Healthcare | 1.27% | 0.62% |
#19
21
Prev: #40
|
3.5 |
—
|
21,466 | 69.1% |
P
S
|
52,523 | $24,462,062 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 1.25% | 0.92% |
#20
8
Prev: #28
|
2.5 |
—
|
1,116 | 5.9% |
P
S
|
20,116 | $24,127,734 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GERN
GERON CORP
|
Healthcare | 1.24% | 1.48% |
#21
1
Prev: #20
|
1.0 |
—
|
-117,461 | -0.6% |
P
S
|
18,717,422 | $23,958,300 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 1.22% | 0.41% |
#22
27
Prev: #49
|
3.5 |
—
|
363,812 | 152.2% |
P
S
|
602,922 | $23,519,987 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OHI
OMEGA HEALTHCAR...
|
Real Estate | 1.20% | 1.35% |
#23
2
Prev: #21
|
1.0 |
—
|
-102,133 | -17.4% |
P
S
|
483,547 | $23,055,521 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PODD
INSULET CORP
|
Healthcare | 1.18% | 1.59% |
#24
6
Prev: #18
|
1.0 |
—
|
5,270 | 3.7% |
P
S
|
148,816 | $22,657,236 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
THC
TENET HEALTHCAR...
|
Healthcare | 1.11% | 0.29% |
#25
32
Prev: #57
|
3.4 |
—
|
84,687 | 287.0% |
P
S
|
114,199 | $21,364,349 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.10% | — |
#26
Prev: #—
|
3.9 |
—
|
51,145 | — |
NEW
|
51,145 | $21,257,396 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WELL
WELLTOWER INC
|
Real Estate | 1.03% | 1.89% |
#27
11
Prev: #16
|
0.4 |
—
|
-93,641 | -51.7% |
P
S
|
87,312 | $19,817,205 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 1.02% | 0.75% |
#28
6
Prev: #34
|
0.9 |
—
|
-165,397 | -11.7% |
P
S
|
1,249,441 | $19,578,740 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.98% | — |
#29
Prev: #—
|
3.9 |
—
|
490,235 | — |
NEW
|
490,235 | $18,972,094 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 0.97% | 1.53% |
#30
11
Prev: #19
|
0.4 |
—
|
-1,174,167 | -38.6% |
P
S
|
1,865,653 | $18,656,530 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MOH
MOLINA HEALTHCA...
|
Healthcare | 0.96% | 0.23% |
#31
31
Prev: #62
|
3.4 |
—
|
47,783 | 145.6% |
P
S
|
80,594 | $18,431,848 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PNTG
PENNANT GROUP I...
|
Healthcare | 0.88% | 0.50% |
#32
12
Prev: #44
|
2.9 |
—
|
148,094 | 47.4% |
P
S
|
460,272 | $17,007,050 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LTC
LTC PPTYS INC
|
Real Estate | 0.84% | 0.63% |
#33
5
Prev: #38
|
2.8 |
—
|
99,594 | 31.0% |
P
S
|
420,640 | $16,173,608 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 0.83% | — |
#34
Prev: #—
|
3.8 |
—
|
149,209 | — |
NEW
|
149,209 | $15,908,664 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.79% | 0.74% |
#35
Prev: #35
|
2.3 |
—
|
117,873 | 16.5% |
P
S
|
831,142 | $15,268,079 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.74% | 0.62% |
#36
3
Prev: #39
|
2.8 |
—
|
41,839 | 20.1% |
P
S
|
249,607 | $14,282,513 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AMN
AMN HEALTHCARE ...
|
Healthcare | 0.72% | — |
#37
Prev: #—
|
3.8 |
—
|
428,531 | — |
NEW
|
428,531 | $13,871,548 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.69% | — |
#38
Prev: #—
|
3.8 |
—
|
127,931 | — |
NEW
|
127,931 | $13,384,141 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.69% | 0.61% |
#39
2
Prev: #41
|
0.8 |
—
|
-20,577 | -5.1% |
P
S
|
386,383 | $13,361,124 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.69% | 0.79% |
#40
9
Prev: #31
|
2.3 |
—
|
369,983 | 11.6% |
P
S
|
3,558,497 | $13,344,364 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.64% | — |
#41
Prev: #—
|
3.8 |
—
|
31,171 | — |
NEW
|
31,171 | $12,381,745 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.62% | 0.40% |
#42
9
Prev: #51
|
3.2 |
—
|
66,958 | 51.7% |
P
S
|
196,532 | $11,862,672 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.58% | — |
#43
Prev: #—
|
3.7 |
—
|
747,994 | — |
NEW
|
747,994 | $11,175,030 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 0.58% | — |
#44
Prev: #—
|
3.7 |
—
|
41,621 | — |
NEW
|
41,621 | $11,101,153 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
BRKR
BRUKER CORP
|
Healthcare | 0.57% | 0.22% |
#45
19
Prev: #64
|
3.2 |
—
|
65,881 | 56.3% |
P
S
|
182,894 | $11,006,561 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MRNA
MODERNA INC
|
Healthcare | 0.55% | 0.43% |
#46
2
Prev: #48
|
0.7 |
—
|
-7,586 | -4.7% |
P
S
|
152,122 | $10,653,104 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.55% | 0.35% |
#47
7
Prev: #54
|
2.7 |
—
|
58,266 | 42.2% |
P
S
|
196,302 | $10,535,528 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
CALL
INSMED INC
|
CALL Option | 0.53% | 0.81% |
#48
18
Prev: #30
|
0.7 |
—
|
2,600 | 2.8% |
P
S
|
96,600 | $10,299,492 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.53% | 0.16% |
#49
25
Prev: #74
|
2.7 |
—
|
56,462 | 35.1% |
P
S
|
217,185 | $10,216,382 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.49% | 0.20% |
#50
17
Prev: #67
|
0.7 |
—
|
-5,099 | -0.8% |
P
S
|
672,825 | $9,520,474 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 152 holdings